FIELD: medicine; gastroenterology.
SUBSTANCE: treatment of chronic viral hepatitis type C is provided by oral introduction of Reaferon-EC-Lipint dosed 1 million ME twice a day within 10 days, thereafter introduced in the same dosage once a day within 6 months. Furthermore in addition Ronkoleukine is introduced orally in dosage 500 thousand ME twice a week within 3 months.
EFFECT: effective treatment in patients suffering from cytopenic, autoimmune syndrome combined with immunodeficiency with contraindications to injection interferons.
2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF PREVENTION OF CHRONIC VIRAL HEPATITIS TYPE C RECURRENT AFTER VIRUS REMISSION | 2007 |
|
RU2348412C1 |
METHOD OF CHRONIC VIRUS HEPATITIS B TREATMENT | 2006 |
|
RU2365381C2 |
METHOD OF TREATING CHRONIC VIRAL HEPATITIS C WITH MEDICATIONS IN LIPOSOMAL FORM | 2011 |
|
RU2475263C1 |
METHOD OF TREATING EXUDATIVE OTITIS MEDIA IN CHILDREN | 2010 |
|
RU2424821C1 |
METHOD OF TREATING GASTRIC AND/OR DUODENAL ULCER | 2013 |
|
RU2517789C1 |
METHOD OF TREATING PATIENT WITH CHRONIC BRUCELLOSIS | 2009 |
|
RU2423143C2 |
METHOD OF TREATING TICK-BORNE ENCEPHALITIS | 2011 |
|
RU2473364C2 |
METHOD OF TREATING PATIENTS WITH CHRONIC VIRAL HEPATITIS TYPE C, GENOTYPE 3a | 2009 |
|
RU2400229C1 |
METHOD FOR PREDICTION OF IF THERAPY EFFECTIVENESS FOR VIRAL HEPATITIS IN CHILDREN | 2008 |
|
RU2379689C1 |
METHOD FOR CARRYING OUT INTERFERON THERAPY | 1995 |
|
RU2105566C1 |
Authors
Dates
2009-02-10—Published
2006-12-25—Filed